Rani Therapeutics (RANI) news
Recent news
Rani Therapeutics announces acceptance into U.S. FDA's emerging technology program (ETP)
AInvest Wire · Oct 5, 2026PegBio: collaboration with Nasdaq-listed Rani Therapeutics
Rani Therapeutics (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, has announced a research and development collaboration with PegBio Co., Ltd., a company specializing in obesity and metabolic disease therapeutics. The partnership aims to…
AInvest Wire · Jul 10, 2026Rani Therapeutics announces research and development collaboration with PegBio to expand obesity pipeline across multiple novel candidates
AInvest Wire · Jul 9, 2026Rani Therapeutics appoints Nicholas Maestas as chief financial officer
AInvest Wire · Jun 29, 2026Senior Iranian official: Any direct US intervention on the front line will face unprecedented threat to enemy ships.
Senior Iranian official: Any direct US intervention on the front line will face unprecedented threat to enemy ships. In a defiant statement, a senior Iranian official has warned that any direct U.S. intervention in the ongoing conflict between Israel and Iran would face unprecedented threats to…
AInvest Wire · Jun 18, 2025Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.